Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for David A Ramsay. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at David A Ramsay har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SVRA / Savara Inc. Director 2.513.642
US:LJPC / La Jolla Pharmaceutical Co. Director 0
US:HALO / Halozyme Therapeutics, Inc. VP and Chief Financial Officer 21.262
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af David A Ramsay. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb HALO / Halozyme Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HALO / Halozyme Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-09-16 HALO RAMSAY DAVID A 25.000 8,9000 25.000 8,9000 222.500 309 24.7500 396.250 178,09

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insidersalg HALO / Halozyme Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HALO / Halozyme Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insiderkøb MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HALO / Halozyme Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-03-31 SVRA RAMSAY DAVID A 150.000 2,7750 150.000 2,7750 416.250 161 3.8500 161.250 38,74
2024-11-18 SVRA RAMSAY DAVID A 100.000 2,8760 100.000 2,8760 287.600
2023-05-26 SVRA RAMSAY DAVID A 37.124 2,6290 37.124 2,6290 97.599
2023-05-25 SVRA RAMSAY DAVID A 12.876 2,5730 12.876 2,5730 33.130
2023-05-24 SVRA RAMSAY DAVID A 50.000 2,5560 50.000 2,5560 127.800
2022-12-30 SVRA RAMSAY DAVID A 29.000 1,5460 29.000 1,5460 44.834
2022-12-29 SVRA RAMSAY DAVID A 7.000 1,5360 7.000 1,5360 10.752
2022-12-28 SVRA RAMSAY DAVID A 3.293 1,4950 3.293 1,4950 4.923
2022-12-23 SVRA RAMSAY DAVID A 15.707 1,4430 15.707 1,4430 22.665
2022-12-22 SVRA RAMSAY DAVID A 41.414 1,4760 41.414 1,4760 61.127
2022-12-20 SVRA RAMSAY DAVID A 13.830 1,5010 13.830 1,5010 20.759
2022-12-20 SVRA RAMSAY DAVID A 3.586 1,4800 3.586 1,4800 5.307
2022-12-19 SVRA RAMSAY DAVID A 40.719 1,4940 40.719 1,4940 60.834
2022-12-16 SVRA RAMSAY DAVID A 341 1,5000 341 1,5000 512
2022-11-23 SVRA RAMSAY DAVID A 4.610 1,4390 4.610 1,4390 6.634
2022-11-22 SVRA RAMSAY DAVID A 15.495 1,4210 15.495 1,4210 22.018
2022-11-21 SVRA RAMSAY DAVID A 25.005 1,4210 25.005 1,4210 35.532
2022-11-18 SVRA RAMSAY DAVID A 16.100 1,3420 16.100 1,3420 21.606
2022-11-17 SVRA RAMSAY DAVID A 8.900 1,2700 8.900 1,2700 11.303
2022-09-27 SVRA RAMSAY DAVID A 73.893 1,3720 73.893 1,3720 101.381
2022-09-26 SVRA RAMSAY DAVID A 31.107 1,3840 31.107 1,3840 43.052
2022-09-23 SVRA RAMSAY DAVID A 30.000 1,4220 30.000 1,4220 42.660
2022-09-20 SVRA RAMSAY DAVID A 600 1,4500 600 1,4500 870
2022-09-19 SVRA RAMSAY DAVID A 1.400 1,4570 1.400 1,4570 2.040
2022-09-16 SVRA RAMSAY DAVID A 6.000 1,4420 6.000 1,4420 8.652
2022-09-08 SVRA RAMSAY DAVID A 29.000 1,3990 29.000 1,3990 40.571
2022-09-07 SVRA RAMSAY DAVID A 2.130 1,3850 2.130 1,3850 2.950
2022-09-06 SVRA RAMSAY DAVID A 870 1,3800 870 1,3800 1.201
2022-09-01 SVRA RAMSAY DAVID A 39.768 1,4200 39.768 1,4200 56.471
2022-08-31 SVRA RAMSAY DAVID A 39.494 1,4230 39.494 1,4230 56.200
2022-08-30 SVRA RAMSAY DAVID A 20.738 1,4110 20.738 1,4110 29.261
2022-06-22 SVRA RAMSAY DAVID A 39.000 1,4450 39.000 1,4450 56.355
2022-06-21 SVRA RAMSAY DAVID A 21.094 1,3800 21.094 1,3800 29.110
2022-06-17 SVRA RAMSAY DAVID A 39.906 1,3260 39.906 1,3260 52.915
2021-12-30 SVRA RAMSAY DAVID A 35.000 1,2960 35.000 1,2960 45.360
2021-12-29 SVRA RAMSAY DAVID A 15.000 1,2450 15.000 1,2450 18.675
2021-12-17 SVRA RAMSAY DAVID A 25.000 1,1290 25.000 1,1290 28.225
2021-12-15 SVRA RAMSAY DAVID A 15.000 1,0840 15.000 1,0840 16.260
2021-12-10 SVRA RAMSAY DAVID A 35.000 1,0390 35.000 1,0390 36.365
2021-12-08 SVRA RAMSAY DAVID A 13.157 1,0500 13.157 1,0500 13.815
2021-12-07 SVRA RAMSAY DAVID A 11.843 1,0470 11.843 1,0470 12.400
2021-12-02 SVRA RAMSAY DAVID A 21.394 1,0860 21.394 1,0860 23.234
2021-12-01 SVRA RAMSAY DAVID A 9.000 1,0850 9.000 1,0850 9.765
2021-12-01 SVRA RAMSAY DAVID A 3.606 1,0800 3.606 1,0800 3.894
2021-11-30 SVRA RAMSAY DAVID A 16.000 1,0870 16.000 1,0870 17.392
2021-11-22 SVRA RAMSAY DAVID A 90.000 1,0780 90.000 1,0780 97.020
2021-11-19 SVRA RAMSAY DAVID A 49.800 1,0690 49.800 1,0690 53.236
2021-11-18 SVRA RAMSAY DAVID A 60.200 1,0820 60.200 1,0820 65.136
2021-09-30 SVRA RAMSAY DAVID A 50.000 1,2980 50.000 1,2980 64.900
2021-09-29 SVRA RAMSAY DAVID A 47.500 1,2770 47.500 1,2770 60.658
2021-09-28 SVRA RAMSAY DAVID A 39.552 1,2850 39.552 1,2850 50.824
2021-08-18 SVRA RAMSAY DAVID A 12.948 1,1800 12.948 1,1800 15.279
2021-08-18 SVRA RAMSAY DAVID A 17.788 1,2200 17.788 1,2200 21.701
2021-08-17 SVRA RAMSAY DAVID A 66.554 1,1750 66.554 1,1750 78.201
2021-05-19 SVRA RAMSAY DAVID A 5.003 1,5800 5.003 1,5800 7.905
2021-05-18 SVRA RAMSAY DAVID A 50.000 1,6220 50.000 1,6220 81.100
2021-03-15 SVRA RAMSAY DAVID A 689.655 1,4500 689.655 1,4500 1.000.000
2019-06-28 SVRA RAMSAY DAVID A 18.000 2,3300 18.000 2,3300 41.940
2019-06-28 SVRA RAMSAY DAVID A 12.157 2,3500 12.157 2,3500 28.569
2019-06-28 SVRA RAMSAY DAVID A 5.000 2,3600 5.000 2,3600 11.800
2019-06-27 SVRA RAMSAY DAVID A 5.000 2,4500 5.000 2,4500 12.250
2019-06-27 SVRA RAMSAY DAVID A 5.000 2,4200 5.000 2,4200 12.100
2019-06-27 SVRA RAMSAY DAVID A 5.000 2,4000 5.000 2,4000 12.000
2019-06-27 SVRA RAMSAY DAVID A 5.000 2,3900 5.000 2,3900 11.950
2019-06-27 SVRA RAMSAY DAVID A 2.300 2,3800 2.300 2,3800 5.474
2019-06-26 SVRA RAMSAY DAVID A 900 2,3800 900 2,3800 2.142
2019-06-18 SVRA RAMSAY DAVID A 5.000 2,3600 5.000 2,3600 11.800
2019-06-18 SVRA RAMSAY DAVID A 10.215 2,3500 10.215 2,3500 24.005
2019-06-17 SVRA RAMSAY DAVID A 10.000 2,3900 10.000 2,3900 23.900
2019-06-17 SVRA RAMSAY DAVID A 10.000 2,3800 10.000 2,3800 23.800
2019-06-17 SVRA RAMSAY DAVID A 5.000 2,3700 5.000 2,3700 11.850
2017-06-07 SVRA RAMSAY DAVID A 21.000 4,7500 21.000 4,7500 99.750
2012-05-14 ANX RAMSAY DAVID A 50.000 0,5393 50.000 0,5393 26.965
2012-05-10 ANX RAMSAY DAVID A 40.000 0,5653 40.000 0,5653 22.612
2012-05-09 ANX RAMSAY DAVID A 10.000 0,5500 10.000 0,5500 5.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Insider Trades
Insidersalg MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HALO / Halozyme Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af David A Ramsay som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-01 2025-03-31 4 SVRA Savara Inc
Common Stock
P - Purchase 150.000 2.513.642 6,35 2,78 416.250 6.975.357
2024-12-16 2024-12-12 4 SVRA Savara Inc
Common Stock
A - Award 40.000 2.363.642 1,72
2024-11-18 2024-11-18 4 SVRA Savara Inc
Common Stock
P - Purchase 100.000 2.323.642 4,50 2,88 287.600 6.682.794
2023-12-15 2023-12-14 4 SVRA Savara Inc
Common Stock
A - Award 22.500 2.223.642 1,02
2023-05-26 2023-05-26 4 SVRA Savara Inc
Common Stock
P - Purchase 37.124 2.201.142 1,72 2,63 97.599 5.786.802
2023-05-26 2023-05-25 4 SVRA Savara Inc
Common Stock
P - Purchase 12.876 2.164.018 0,60 2,57 33.130 5.568.018
2023-05-26 2023-05-24 4 SVRA Savara Inc
Common Stock
P - Purchase 50.000 2.151.142 2,38 2,56 127.800 5.498.319
2023-01-03 2022-12-30 4 SVRA Savara Inc
Common Stock
P - Purchase 29.000 2.101.142 1,40 1,55 44.834 3.248.366
2023-01-03 2022-12-29 4 SVRA Savara Inc
Common Stock
P - Purchase 7.000 2.072.142 0,34 1,54 10.752 3.182.810
2022-12-28 2022-12-28 4 SVRA Savara Inc
Common Stock
P - Purchase 3.293 2.065.142 0,16 1,50 4.923 3.087.387
2022-12-28 2022-12-23 4 SVRA Savara Inc
Common Stock
P - Purchase 15.707 2.061.849 0,77 1,44 22.665 2.975.248
2022-12-22 2022-12-22 4 SVRA Savara Inc
Common Stock
P - Purchase 41.414 2.046.142 2,07 1,48 61.127 3.020.106
2022-12-22 2022-12-20 4 SVRA Savara Inc
Common Stock
P - Purchase 3.586 2.004.728 0,18 1,48 5.307 2.966.997
2022-12-20 2022-12-20 4 SVRA Savara Inc
Common Stock
P - Purchase 13.830 2.001.142 0,70 1,50 20.759 3.003.714
2022-12-20 2022-12-19 4 SVRA Savara Inc
Common Stock
P - Purchase 40.719 1.987.312 2,09 1,49 60.834 2.969.044
2022-12-20 2022-12-16 4 SVRA Savara Inc
Common Stock
P - Purchase 341 1.946.593 0,02 1,50 512 2.919.890
2022-11-25 2022-11-23 4 SVRA Savara Inc
Common Stock
P - Purchase 4.610 1.946.252 0,24 1,44 6.634 2.800.657
2022-11-25 2022-11-22 4 SVRA Savara Inc
Common Stock
P - Purchase 15.495 1.941.642 0,80 1,42 22.018 2.759.073
2022-11-21 2022-11-21 4 SVRA Savara Inc
Common Stock
P - Purchase 25.005 1.926.147 1,32 1,42 35.532 2.737.055
2022-11-21 2022-11-18 4 SVRA Savara Inc
Common Stock
P - Purchase 16.100 1.901.142 0,85 1,34 21.606 2.551.333
2022-11-21 2022-11-17 4 SVRA Savara Inc
Common Stock
P - Purchase 8.900 1.885.042 0,47 1,27 11.303 2.394.003
2022-09-27 2022-09-27 4 SVRA Savara Inc
Common Stock
P - Purchase 73.893 1.876.142 4,10 1,37 101.381 2.574.067
2022-09-27 2022-09-26 4 SVRA Savara Inc
Common Stock
P - Purchase 31.107 1.802.249 1,76 1,38 43.052 2.494.313
2022-09-27 2022-09-23 4 SVRA Savara Inc
Common Stock
P - Purchase 30.000 1.771.142 1,72 1,42 42.660 2.518.564
2022-09-20 2022-09-20 4 SVRA Savara Inc
Common Stock
P - Purchase 600 1.741.142 0,03 1,45 870 2.524.656
2022-09-20 2022-09-19 4 SVRA Savara Inc
Common Stock
P - Purchase 1.400 1.740.542 0,08 1,46 2.040 2.535.970
2022-09-20 2022-09-16 4 SVRA Savara Inc
Common Stock
P - Purchase 6.000 1.739.142 0,35 1,44 8.652 2.507.843
2022-09-08 2022-09-08 4 SVRA Savara Inc
Common Stock
P - Purchase 29.000 1.733.142 1,70 1,40 40.571 2.424.666
2022-09-08 2022-09-07 4 SVRA Savara Inc
Common Stock
P - Purchase 2.130 1.704.142 0,13 1,38 2.950 2.360.237
2022-09-08 2022-09-06 4 SVRA Savara Inc
Common Stock
P - Purchase 870 1.702.012 0,05 1,38 1.201 2.348.777
2022-09-01 2022-09-01 4 SVRA Savara Inc
Common Stock
P - Purchase 39.768 1.701.142 2,39 1,42 56.471 2.415.622
2022-09-01 2022-08-31 4 SVRA Savara Inc
Common Stock
P - Purchase 39.494 1.661.374 2,44 1,42 56.200 2.364.135
2022-09-01 2022-08-30 4 SVRA Savara Inc
Common Stock
P - Purchase 20.738 1.621.880 1,30 1,41 29.261 2.288.473
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
D - Sale to Issuer -100.000 0 -100,00 6,23 -623.000
2022-06-22 2022-06-22 4 SVRA Savara Inc
Common Stock
P - Purchase 39.000 1.601.142 2,50 1,44 56.355 2.313.650
2022-06-22 2022-06-21 4 SVRA Savara Inc
Common Stock
P - Purchase 21.094 1.562.142 1,37 1,38 29.110 2.155.756
2022-06-22 2022-06-17 4 SVRA Savara Inc
Common Stock
P - Purchase 39.906 1.541.048 2,66 1,33 52.915 2.043.430
2022-01-14 2022-01-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 30.000 30.000
2021-12-30 2021-12-30 4 SVRA Savara Inc
Common Stock
P - Purchase 35.000 1.501.142 2,39 1,30 45.360 1.945.480
2021-12-30 2021-12-29 4 SVRA Savara Inc
Common Stock
P - Purchase 15.000 1.466.142 1,03 1,24 18.675 1.825.347
2021-12-17 2021-12-17 4 SVRA Savara Inc
Common Stock
P - Purchase 25.000 1.451.142 1,75 1,13 28.225 1.638.339
2021-12-17 2021-12-15 4 SVRA Savara Inc
Common Stock
P - Purchase 15.000 1.426.142 1,06 1,08 16.260 1.545.938
2021-12-14 2021-12-14 4 SVRA Savara Inc
Stock Option (Right to Buy)
A - Award 40.000 40.000
2021-12-13 2021-12-10 4 SVRA Savara Inc
Common Stock
P - Purchase 35.000 1.411.142 2,54 1,04 36.365 1.466.177
2021-12-09 2021-12-08 4 SVRA Savara Inc
Common Stock
P - Purchase 13.157 1.376.142 0,97 1,05 13.815 1.444.949
2021-12-09 2021-12-07 4 SVRA Savara Inc
Common Stock
P - Purchase 11.843 1.362.985 0,88 1,05 12.400 1.427.045
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 3.000 100.000 3,09 3,87 11.610 387.000
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 97.000 1,04 3,84 3.840 372.480
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.215 96.000 2,36 3,82 8.461 366.720
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 93.785 1,08 3,81 3.810 357.321
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 92.785 1,09 3,80 3.800 352.583
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 785 91.785 0,86 3,77 2.959 346.029
2021-12-06 2021-12-06 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 91.000 1,11 3,75 3.750 341.250
2021-12-06 2021-12-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 90.000 1,12 3,69 3.690 332.100
2021-12-06 2021-12-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 89.000 1,14 3,68 3.680 327.520
2021-12-06 2021-12-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 399 88.000 0,46 3,64 1.452 320.320
2021-12-06 2021-12-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 87.601 2,34 3,63 7.260 317.992
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 85.601 1,18 3,80 3.800 325.284
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 84.601 1,20 3,78 3.780 319.792
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.400 83.601 2,96 3,74 8.976 312.668
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.100 81.201 1,37 3,73 4.103 302.880
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 80.101 1,26 3,71 3.710 297.175
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 79.101 2,59 3,70 7.400 292.674
2021-12-06 2021-12-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.601 77.101 2,12 3,69 5.908 284.503
2021-12-02 2021-12-02 4 SVRA Savara Inc
Common Stock
P - Purchase 21.394 1.351.142 1,61 1,09 23.234 1.467.340
2021-12-02 2021-12-01 4 SVRA Savara Inc
Common Stock
P - Purchase 3.606 1.329.748 0,27 1,08 3.894 1.436.128
2021-12-01 2021-12-01 4 SVRA Savara Inc
Common Stock
P - Purchase 9.000 1.326.142 0,68 1,08 9.765 1.438.864
2021-12-01 2021-11-30 4 SVRA Savara Inc
Common Stock
P - Purchase 16.000 1.317.142 1,23 1,09 17.392 1.431.733
2021-11-22 2021-11-22 4 SVRA Savara Inc
Common Stock
P - Purchase 90.000 1.301.142 7,43 1,08 97.020 1.402.631
2021-11-22 2021-11-19 4 SVRA Savara Inc
Common Stock
P - Purchase 49.800 1.211.142 4,29 1,07 53.236 1.294.711
2021-11-22 2021-11-18 4 SVRA Savara Inc
Common Stock
P - Purchase 60.200 1.161.342 5,47 1,08 65.136 1.256.572
2021-11-19 2021-11-17 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 7.500 75.500 11,03 4,23 31.725 319.365
2021-09-30 2021-09-30 4 SVRA Savara Inc
Common Stock
P - Purchase 50.000 1.101.142 4,76 1,30 64.900 1.429.282
2021-09-30 2021-09-29 4 SVRA Savara Inc
Common Stock
P - Purchase 47.500 1.051.142 4,73 1,28 60.658 1.342.308
2021-09-30 2021-09-28 4 SVRA Savara Inc
Common Stock
P - Purchase 39.552 1.003.642 4,10 1,28 50.824 1.289.680
2021-08-19 2021-08-18 4 SVRA Savara Inc
Common Stock
P - Purchase 17.788 964.090 1,88 1,22 21.701 1.176.190
2021-08-19 2021-08-18 4 SVRA Savara Inc
Common Stock
P - Purchase 12.948 946.302 1,39 1,18 15.279 1.116.636
2021-08-19 2021-08-17 4 SVRA Savara Inc
Common Stock
P - Purchase 66.554 933.354 7,68 1,18 78.201 1.096.691
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 600 68.000 0,89 3,60 2.160 244.800
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 400 67.400 0,60 3,57 1.428 240.618
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 67.000 1,52 3,54 3.540 237.180
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 66.000 1,54 3,53 3.530 232.980
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 65.000 3,17 3,52 7.040 228.800
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 63.000 1,61 3,51 3.510 221.130
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 3.000 62.000 5,08 3,50 10.500 217.000
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 59.000 3,51 3,49 6.980 205.910
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 4.000 57.000 7,55 3,48 13.920 198.360
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 53.000 1,92 3,46 3.460 183.380
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 52.000 1,96 3,45 3.450 179.400
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 3.000 51.000 6,25 3,44 10.320 175.440
2021-05-20 2021-05-19 4 SVRA Savara Inc
Common Stock
P - Purchase 5.003 866.800 0,58 1,58 7.905 1.369.544
2021-05-18 2021-05-18 4 SVRA Savara Inc
Common Stock
P - Purchase 50.000 861.797 6,16 1,62 81.100 1.397.835
2021-03-15 2021-03-15 4 SVRA Savara Inc
Common Stock
P - Purchase 689.655 811.797 564,63 1,45 1.000.000 1.177.106
2020-12-17 2020-12-16 4 SVRA Savara Inc
Stock Option (Right to Buy)
A - Award 40.000 40.000
2020-12-14 2020-12-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 30.000 30.000
2020-09-10 2020-09-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 48.000 2,13 3,83 3.830 183.840
2020-08-24 2020-08-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 47.000 2,17 3,73 3.730 175.310
2020-08-24 2020-08-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 46.000 2,22 3,74 3.740 172.040
2020-08-24 2020-08-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 4.000 45.000 9,76 3,75 15.000 168.750
2020-08-24 2020-08-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 41.000 2,50 3,82 3.818 156.558
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 5.000 40.000 14,29 4,08 20.400 163.200
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 35.000 6,06 4,04 8.080 141.400
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 33.000 6,45 4,03 8.060 132.990
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 31.000 3,33 4,02 4.020 124.620
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 30.000 7,14 4,01 8.020 120.300
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 28.000 3,70 4,00 4.000 112.000
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 27.000 3,85 3,98 3.980 107.460
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 26.000 4,00 3,97 3.970 103.220
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 25.000 4,17 3,95 3.950 98.750
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 24.000 9,09 3,94 7.888 94.656
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 22.000 4,76 3,93 3.930 86.460
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 21.000 5,00 3,92 3.920 82.320
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 20.000 5,26 3,90 3.900 78.000
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 19.000 5,56 3,88 3.880 73.720
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 18.000 5,88 3,87 3.870 69.660
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.000 17.000 6,25 3,86 3.860 65.620
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 16.000 14,29 3,85 7.700 61.600
2020-08-24 2020-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.000 14.000 16,67 3,84 7.680 53.760
2020-08-24 2020-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 2.530 12.000 26,72 4,18 10.575 50.160
2020-08-24 2020-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 3.470 9.470 57,83 4,17 14.470 39.490
2020-08-24 2020-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 6.000 6.000 4,17 25.015 25.015
2019-12-26 2019-12-20 4 SVRA Savara Inc
Stock Option (Right to Buy)
A - Award 12.000 12.000
2019-12-23 2019-12-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 12.000 12.000
2019-10-24 2019-10-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 18.000 18.000
2019-06-28 2019-06-28 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 122.142 4,27 2,36 11.800 288.255
2019-06-28 2019-06-28 4 SVRA Savara Inc
Common Stock
P - Purchase 12.157 117.142 11,58 2,35 28.569 275.284
2019-06-28 2019-06-28 4 SVRA Savara Inc
Common Stock
P - Purchase 18.000 104.985 20,69 2,33 41.940 244.615
2019-06-28 2019-06-27 4 SVRA Savara Inc
Common Stock
P - Purchase 2.300 86.985 2,72 2,38 5.474 207.024
2019-06-28 2019-06-27 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 84.685 6,27 2,39 11.950 202.397
2019-06-28 2019-06-27 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 79.685 6,69 2,40 12.000 191.244
2019-06-28 2019-06-27 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 74.685 7,18 2,42 12.100 180.738
2019-06-28 2019-06-27 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 69.685 7,73 2,45 12.250 170.728
2019-06-28 2019-06-26 4 SVRA Savara Inc
Common Stock
P - Purchase 900 64.685 1,41 2,38 2.142 153.950
2019-06-19 2019-06-18 4 SVRA Savara Inc
Common Stock
P - Purchase 10.215 63.785 19,07 2,35 24.005 149.895
2019-06-19 2019-06-18 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 53.570 10,29 2,36 11.800 126.425
2019-06-19 2019-06-17 4 SVRA Savara Inc
Common Stock
P - Purchase 5.000 48.570 11,48 2,37 11.850 115.111
2019-06-19 2019-06-17 4 SVRA Savara Inc
Common Stock
P - Purchase 10.000 43.570 29,79 2,38 23.800 103.697
2019-06-19 2019-06-17 4 SVRA Savara Inc
Common Stock
P - Purchase 10.000 33.570 42,43 2,39 23.900 80.232
2019-06-19 2017-04-27 4 SVRA Savara Inc
Restricted Stock Units
M - Exercise -1.142 0 -100,00
2019-06-19 2017-04-27 4 SVRA Savara Inc
Common Stock
M - Exercise 1.142 23.570 5,09
2018-12-14 2018-12-13 4 SVRA Savara Inc
Stock Option (Right to Buy)
A - Award 12.000 12.000
2017-06-09 2017-06-07 4 SVRA Savara Inc
Common Stock
P - Purchase 21.000 22.428 1.470,59 4,75 99.750 106.533
2017-05-26 2017-05-25 4 SVRA Savara Inc
Stock Option (Right to Buy)
A - Award 3.750 3.750
2017-01-23 2017-01-20 4 MSTX Mast Therapeutics, Inc.
Restricted Stock Units
A - Award 79.962 79.962
2016-06-17 2016-06-15 4 MSTX Mast Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 79.551 79.551
2015-06-12 2015-06-11 4 MSTX Mast Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 82.963 82.963
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -7.088 21.262 -25,00
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -2.660 364.320 -0,72 13,87 -36.894 5.053.118
2015-02-06 2015-02-06 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 7.088 366.980 1,97
2015-02-06 2015-02-04 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 28.000 28.000
2015-02-06 2015-02-04 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 45.000 45.000
2015-02-04 2015-02-04 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Award
M - Exercise -2.213 4.424 -33,34
2015-02-04 2015-02-04 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 2.213 359.892 0,62
2015-02-04 2015-02-02 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Award
M - Exercise -3.125 3.125 -50,00
2015-02-04 2015-02-02 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 3.125 357.679 0,88
2014-12-22 2014-12-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -17.625 42.594 -29,27
2014-12-22 2014-12-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
F - Taxes -6.621 354.554 -1,83 9,46 -62.635 3.354.081
2014-12-22 2014-12-22 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 17.625 361.175 5,13
2014-12-01 2014-12-01 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
M - Exercise -20.058 0 -100,00
2014-12-01 2014-12-01 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 20.058 343.550 6,20 2,02 40.517 693.971
2014-09-16 2014-09-16 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
M - Exercise -50.000 0 -100,00 2,05 -102.500
2014-09-16 2014-09-16 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
P - Purchase 25.000 323.492 8,38 8,90 222.500 2.879.079
2014-09-16 2014-09-16 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 50.000 298.492 20,12 2,05 102.500 611.909
2014-06-20 2014-06-19 4 MSTX Mast Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 46.609 46.609
2014-02-10 2014-02-06 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 28.350 28.350
2014-02-10 2014-02-06 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 45.000 45.000 13,10 589.500 589.500
2014-02-04 2014-02-04 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Award
M - Exercise -2.213 6.637 -25,01
2014-02-04 2014-02-04 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 2.213 248.492 0,90
2014-02-04 2014-02-02 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Award
M - Exercise -3.125 6.250 -33,33
2014-02-04 2014-02-02 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 3.125 246.279 1,29
2013-12-23 2013-12-20 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
M - Exercise -10.281 60.219 -14,58
2013-12-23 2013-12-20 4 HALO HALOZYME THERAPEUTICS INC
Common stock
M - Exercise 6.419 243.154 2,71
2013-09-16 2013-09-16 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
M - Exercise -130.000 0 -100,00 0,39 -50.700
2013-09-16 2013-09-16 4 HALO HALOZYME THERAPEUTICS INC
Common Stock
M - Exercise 130.000 236.735 121,80 0,39 50.700 92.327
2013-06-21 2013-06-19 4 MSTX Mast Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 62.451 62.451
2013-05-24 2013-05-22 4 HALO HALOZYME THERAPEUTICS INC
Restricted Stock Units
A - Award 70.500 70.500
2013-05-24 2013-05-22 4 HALO HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock
A - Award 117.500 117.500 7,17 842.475 842.475
2013-05-24 3 HALO HALOZYME THERAPEUTICS INC
Common Stock
105.000
2012-07-30 2012-07-28 4 ANX ADVENTRX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 27.310 27.310
2012-05-14 2012-05-14 4 ANX ADVENTRX PHARMACEUTICALS INC
Common Stock
P - Purchase 50.000 100.000 100,00 0,54 26.965 53.930
2012-05-10 2012-05-10 4 ANX ADVENTRX PHARMACEUTICALS INC
Common Stock
P - Purchase 40.000 50.000 400,00 0,57 22.612 28.265
2012-05-10 2012-05-09 4 ANX ADVENTRX PHARMACEUTICALS INC
Common Stock
P - Purchase 10.000 10.000 0,55 5.500 5.500
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)